Oh Oh Oh Ozempic

💊The Hormone vs. The Hype?

Inside Health
November 03, 2025

Inside Health Weekly

Are GLP-1 drugs just a little shot of self-control?

It seems that the hottest red-carpet accessory isn’t a bag, it’s a prescription. Ozempic’s gone from pharmacy to fashion statement… what’s going on?

GLP-1 drugs became the modern health flex overnight: half science, half status symbol. But behind the glow-ups and before-and-afters is an actual molecule doing some heavy biochemical lifting.

The Rise of Ozempic:

Ozempic’s biggest flex? Lifting the economy.

But like any good transformation story, it didn’t happen overnight. Here’s how it became the market’s favorite metabolism hack.

Early 1990s: Novo Nordisk (Pharmaceutical company) begins exploring hormone ‘GLP-1’ as a target for diabetes and weight regulation
2017: Ozempic receives US FDA approval for adults with type 2 diabetes (not that long ago!)
2019: Oral semiglutide (brand name Rybelsus) is approved for type 2 diabetes – the first daily pill version of its kind
2021: Semaglutide (brand name Wegovy) receives FDA approval for chronic weight management (obesity) in the USA
- Major pivot in the market: Ozempic’s active ingredient becomes central to the weight-loss market
2023: Surge in demand for semaglutide drugs; supply shortages begin globally (the drug becomes a cultural and commercial phenomenon)
2024: Novo Nordisk announces $4.1 billion investment in US manufacturing capacity to meet the demand for Ozempic and Wegovy

Ozempic’s biggest gain? The economy.

Understand the Science:

So what’s the trick behind this magic medication? Let’s break it down.

First, understand that GLP-1 is actually a hormone that is synthesized by your small intestine. GLP-1 drugs are NOT the same as the hormone, GLP-1.

GLP-1 is involved in:

Increasing satiety, or making you feel fuller faster
Triggers insulin release
- Insulin: A hormone that lowers your blood sugar by allowing your body to use up the food you eat as fuel
Slowing digestion

GLP-1 drugs aren’t the actual GLP-1 hormone—they mimic its natural effects. These medications bind to GLP-1 receptors (think of the receptor as a lock and the drug as the key), which activate them, just like the hormone would.

This means that by taking GLP-1 drugs, they act directly on the pancreas to cause what you’d expect from the GLP hormone–decreased appetite, higher levels of insulin, and slowed digestion.

Is GLP-1 for you?

Weight loss isn’t a one-size-fits-all journey—each person’s unique biology can make shedding pounds easier for some and more challenging for others.

GLP-1 drugs aren’t designed to replace healthy habits; instead, they work best as an aid to enhance the results of consistent nutrition, exercise, and overall lifestyle choices.

Below denotes candidates who may benefit from taking these medications:

BMI of 30 or higher
High blood pressure
Heart disease
Sleep apnea
High cholesterol

All of this is to say—don’t let media portrayals convince you that you need these drugs. GLP-1 medications can cause significant side effects and are intended primarily for individuals who have struggled to lose weight despite multiple efforts.

Don’t believe you need to look a certain way to be beautiful. You already are. :) -Tyler; Health Research Director

Being healthy isn’t about achieving a certain appearance; it’s about feeling your best. These drugs are designed to help restore the body’s natural balance, not simply to shed a few extra pounds.

On the Market:

Ozempic isn’t just reshaping waistlines; it’s reshaping markets.

Behind the Ozempic headlines is the pharma powerhouse running the show — Novo Nordisk. Over the past few months, its stock has skyrocketed, transforming this once-niche diabetes company into one of the most valuable in Europe.

Think about it: How many prescription drugs can you actually name off the top of your head? Probably not five. Yet, Ozempic has become a billion-dollar buzzword.

Here’s a breakdown of Novo Nordisk’s latest financial projections:

8–14% sales growth projected for 2025, driven by the global demand for Ozempic and Wegovy.
Operating profit expected to rise 10–16%, continuing the company’s record-breaking performance.
Midyear results show momentum: sales up 18%, operating profit up 29% in the first half of 2025.

Current Market Cap: 259.17B

On the News:

The pharmaceutical industry created one of the most controversial collaborations of the season in early September 2025.

The latest ambassador for Ozempic? Serena Williams. A 23-time Grand Slam champion, global icon, and a role model for millions of women.🎾

Her involvement has sparked a cultural debate: when a symbol of discipline and athletic excellence fronts a drug marketed for quick fixes, what message does that send about health, body image, and the business of wellness?

💬 From Cordelia:

We’re living in a time where science and society are evolving together, and few examples capture that better than the rise of Ozempic. These breakthroughs are reshaping not only how we approach weight management, but how we understand the body itself.

What fascinates me most isn’t just the science… it’s the scale. A single molecule can influence health outcomes, stock markets, and cultural conversations all at once. That’s powerful.

But with that power comes responsibility, to understand what’s happening inside our bodies and around our world. Health literacy means asking questions, following the evidence, and seeing innovation for what it truly is: a tool.

– Cordelia; Inside Health Founder

Announcements – In case you missed it

🚨Inside Health: First Educational Event (11/20/2025 @ 4-5pm CST)
- You’re Invited! Excited to announce our first educational virtual event on hormone health. Join us for a chance to connect, interact, and learn from panel featuring leading industry experts.
  Click on Image to RSVP
🚨Marketing Internship: Spring 2026 Internship
- Inside Health is growing and we are actively looking for Spring 2026 interns… Apply today and join the team!

That’s everything for now! Thanks for hanging out with Inside Health this week. Understanding how you function starts with education, and you’re already doing the work just by being here.

Until Next Time! —The Inside Health Team.